Recently, Sweeney and colleagues demonstrated that melanomas downregulate the glycosyltransferase beta-1,6-N-acetylglucosaminyltransferase (GCNT2) promoting melanoma xenograft growth, colony formation, and cell survival (18). The gene discussed is GCNT2; the disease is melanoma.